Silymarin’s Inhibition and Treatment Effects for Alzheimer’s Disease
As a longstanding problem, Alzheimer’s disease (AD) has stymied researchers in the medical field with its increasing incidence and enormous treatment difficulty. Silymarin has always been valued by researchers for its good efficacy and safety in treating liver disease. Recent studies have...
Main Authors: | Hong Guo, Hui Cao, Xiaowei Cui, Wenxiu Zheng, Shanshan Wang, Jiyang Yu, Zhi Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/9/1748 |
Similar Items
-
Role of pro-inflammatory S100A9 protein in amyloid-neuroinflammatory cascade in Alzheimer’s disease and traumatic brain injury
by: Wang, Chao
Published: (2016) -
β-Asarone Inhibits Amyloid-β by Promoting Autophagy in a Cell Model of Alzheimer's Disease
by: Nanbu Wang, et al.
Published: (2020-01-01) -
DOENÇA DE ALZHEIMER: HIPÓTESES ETIOLÓGICAS E PERSPECTIVAS DE TRATAMENTO
by: Anna De Falco, et al.
Published: (2016-01-01) -
Alzheimer’s disease: amyloid-based pathogenesis and potential therapies
by: Yixiu Zhou, et al.
Published: (2018-06-01) -
Modulatory Effects of Autophagy on APP Processing as a Potential Treatment Target for Alzheimer’s Disease
by: Md. Ataur Rahman, et al.
Published: (2021-12-01)